Operating income increased 38.8%
Operating income changed +38.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$14.8M→-$9.1M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →LUNG financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 2225 bp higher
Operating margin changed +2225 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-62.05%→-39.80%4 prior comparisons
Gross margin moved 586 bp higher
Gross margin changed +586 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
72.11%→77.97%4 prior comparisons
Stock-based compensation decreased 40.5%
Stock-based compensation changed -40.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$6.2M→$3.7M4 prior comparisons
SBC / revenue moved 979 bp lower
SBC / revenue changed -979 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
26.04%→16.25%4 prior comparisons
Selling, general & administrative decreased 18.5%
Selling, general & administrative changed -18.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$26.7M→$21.8M4 prior comparisons
Net income increased 33.6%
Net income changed +33.6% from the comparable as-filed period.
-$15.2M→-$10.1M3 prior comparisons
Inventory / revenue moved 423 bp higher
Inventory / revenue changed +423 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
67.79%→72.02%4 prior comparisons
Cash & equivalents decreased 26.0%
Cash & equivalents changed -26.0% from the comparable as-filed period.
$75.5M→$55.8M2 prior comparisons
Debt increased 1.1%
Debt changed +1.1% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
$37.1M→$37.5M8 prior comparisons
Research & development decreased 5.1%
Research & development changed -5.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$5.3M→$5.0M4 prior comparisons
Revenue decreased 4.6%
Revenue changed -4.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$23.9M→$22.8M4 prior comparisons
Inventory increased 1.3%
Inventory changed +1.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$16.2M→$16.4M4 prior comparisons
Gross profit increased 3.1%
Gross profit changed +3.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$17.2M→$17.7M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.